Diabetes drugs from Eli Lilly and Novo Nordisk, such as Mounjaro, Zepbound, Ozempic, and Wegovy, are expanding beyond ...

Liver cancer is still relatively rare in the United States, representing 2.1% of all new cancer diagnoses in 2025. The report ...

* Researchers at the Danish Headache Center are testing semaglutide along with a very low calorie diet as a treatment for new ...

Strong efficacy and cardiovascular benefits should allow Novo to continue growing sales of GLP-1 therapies in diabetes. Ozempic and Rybelsus helped Novo gain share over Eli Lilly's once-weekly ...

CVS acknowledged that Zepbound has been shown to help people lose more weight than Wegovy, but that Wegovy can still help ...

Sally Love has always enjoyed a drink - but, like many, it was during the Covid pandemic that her alcohol intake began to ...

The hormonal changes of menopause can make the weight gain more resistant to traditional diet and lifestyle changes. But ...

RELATED: Doctors Warn That Drugs Like Ozempic Are Making You “Skinny Fat.” Any time a person suddenly loses weight, they are ...

It's shaping up to be a big year for Boehringer Ingelheim—at least if the FDA plays ball. | Boehringer Chief Medical Officer Lykke Hinsch Gylvin, M.D., set out the German drugmaker's plans to launch ...

The risks of the new weight-loss drugs can sound scary, and there’s lots of talk about side effects. What does evidence show?

Metformin is a safe, effective and cheap, and is showing it has promise for longevity, long Covid, weight control and other ...

With over 40% of Americans classified as obese, the need for effective long-term weight-loss solutions is greater than ever. Obesity can lead to serious health issues like diabetes, heart disease, ...